Trade-Ideas LLC identified Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) as a pre-market leader candidate. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares after opening at $7.98 moved to $8.42 on last trade day and at the end of the day closed at $8.35. Company price to sales ratio in past twelve months was calculated as 34.00 and price to cash ratio as 5.27. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a positive weekly performance of 8.58%.
XOMA Corp (NASDAQ:XOMA) CEO John Varian unloaded 10,000 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.03, for a total value of $60,300.00. XOMA Corp (NASDAQ:XOMA) shares advanced 7.56% in last trading session and ended the day on $6.40. XOMA return on assets is recorded as -152.10%. XOMA Corp (NASDAQ:XOMA) yearly performance is 93.35%.
Rigel Pharmaceuticals (NASDAQ:RIGL) shares rose 13.2% during mid-day trading on Wednesday after the company announced better than expected quarterly earnings, American Banking News reports. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares moved up 5.62% in last trading session and was closed at $4.70 while trading in range of $4.40 – $4.80 – Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) year to date (YTD) performance is 64.91%.
Questcor Pharmaceuticals (NASDAQ:QCOR) CEO Don Bailey sold 40,000 shares of Questcor Pharmaceuticals stock on the open market in a transaction that occurred on Thursday, March 13th. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) weekly performance is 2.41%. On last trading day company shares ended up $65.04. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) distance from 50-day simple moving average (SMA50) is 1.36%. Analysts mean target price for the company is $87.89.